The table below shows Day One Biopharmaceuticals, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$59.00M
-$49.73M
-$25.98M
-$21.56M
-$9.74M
Capital expenditure
$317.00K
$0.00
$26.00K
$15.00K
-
Investing cash flow
-$32.61M
$89.29M
-$11.19M
-$15.00K
-$8.00M
Dividends paid
-
-
-
-
-
Stock buybacks
-
-
DAWN operating cash flow (10-K history)
Day One Biopharmaceuticals, Inc. reported operating cash flow of -$103.76M for fiscal year 2025. That is down 32.8% from -$78.11M in fiscal 2024. Over the 7 fiscal years shown, operating cash flow declined from -$4.51M (FY 2019) to -$103.76M. Figures come from the company's audited annual reports as filed with the SEC.